Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

463 companies

Ticker	Company ▴	Revenue	Net income	Net margin	Return on equity	Revenue growth	Diluted EPS
SMMT	Summit Therapeutics Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$1.08B	n/a	-163.9%	n/a	-$1.44
SBFM	Sunshine Biopharma Inc. Manufacturing · Year ended 2025-12-31 · USD	$36.31M	-$5.98M	-16.5%	-25.9%	4.1%	n/a
SNDX	Syndax Pharmaceuticals Inc Manufacturing · Year ended 2025-12-31 · USD	$172.35M	-$285.42M	-165.6%	-441.6%	627.8%	-$3.29
TLPH	Talphera, Inc. Manufacturing · Year ended 2025-12-31 · USD	$28.0K	-$14.29M	n/m	-83.9%	n/a	n/a
TENX	Tenax Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$52.60M	n/a	-54.2%	n/a	-$1.34
TEVA	Teva Pharmaceutical Industries Ltd Manufacturing · Year ended 2025-12-31 · USD	$17.26B	$1.41B	8.2%	17.8%	4.3%	$1.21
TGTX	TG Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$616.29M	$447.18M	72.6%	69.0%	87.3%	$2.77
GCAN	Trafalgar International, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$331.6K	n/a	n/a	n/a	$0.00
TNGX	Tango Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$62.38M	-$101.59M	-162.9%	-29.3%	48.3%	-$0.87
TELO	Telomir Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$10.41M	n/a	-176.1%	n/a	-$0.33
TPST	Tempest Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$26.26M	n/a	-393.9%	n/a	-$6.33
TXMD	TherapeuticsMD, Inc. Manufacturing · Year ended 2025-12-31 · USD	$3.02M	-$569.0K	-18.8%	-2.1%	71.6%	-$0.05
TBPH	Theravance Biopharma, Inc. Manufacturing · Year ended 2025-12-31 · USD	$107.46M	$105.89M	98.5%	35.7%	66.9%	$2.06
TOVX	Theriva Biologics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$23.74M	n/a	-154.3%	n/a	-$2.08
TNXP	Tonix Pharmaceuticals Holding Corp. Manufacturing · Year ended 2025-12-31 · USD	$13.11M	-$124.02M	-946.2%	-50.6%	29.8%	-$14.57
RNAZ	Transcode Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$34.66M	n/a	-335.4%	n/a	-$52.59
TVTX	Travere Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$490.73M	-$25.55M	-5.2%	-22.2%	110.5%	-$0.29
TRAW	Traws Pharma, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	$9.17M	n/a	n/a	n/a	$0.82
TRVI	Trevi Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$42.76M	n/a	-23.3%	n/a	-$0.32
HURA	TuHURA Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$30.05M	n/a	-143.6%	n/a	-$0.63
TTRX	Turn Therapeutics Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$3.19M	n/a	-68.2%	n/a	-$0.12
TVRD	Tvardi Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$18.21M	n/a	-87.0%	n/a	-$3.26
TYRA	Tyra Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$119.95M	n/a	-46.3%	n/a	-$2.01
UTHR	United Therapeutics Corp Manufacturing · Year ended 2025-12-31 · USD	$3.18B	$1.33B	41.9%	18.8%	10.6%	$27.86
RARE	Ultragenyx Pharmaceutical Inc. Manufacturing · Year ended 2025-12-31 · USD	$673.00M	-$575.00M	-85.4%	n/a	20.2%	-$5.83

Rows per page: 2550 100